EIGEN THERAPEUTICS - About the company
EIGEN THERAPEUTICS is a seed company based in Redwood City (United States), founded in 2021. It operates as a Developer of combination therapeutics for cancer treatment. EIGEN THERAPEUTICS has raised $7M in funding from ZAKA. The company has 3439 active competitors, including 1134 funded and 791 that have exited. Its top competitors include companies like BeiGene, Jazz Pharmaceuticals and Kite Pharma.
Company Details
Developer of combination therapeutics for cancer treatment. It offers a biological and engineering-based drug discovery platform for the development of synergistic therapies that improve efficacy and reduces the toxicity of small molecule therapies and immunotherapies.
- Website
- www.eigentx.com/
- Social
- Email ID
- *****@eigentx.com
Key Metrics
Founded Year
2021
Location
Redwood City, United States
Stage
Seed
Total Funding
$7M in 2 rounds
Latest Funding Round
Ranked
1246th among 3439 active competitors
Employee Count
4 as on Sep 30, 2026
Similar Companies
Legal entities associated with EIGEN THERAPEUTICS
EIGEN THERAPEUTICS is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
EIGEN THERAPEUTICS INC. CIN: 872611846 , United States, Active | Dec 31, 1999 | - | 8 (As on Dec 31, 2024) | - |
Sign up to download EIGEN THERAPEUTICS's company profile
EIGEN THERAPEUTICS's funding and investors
EIGEN THERAPEUTICS has raised a total funding of $7M over 2 rounds. Its first funding round was on Dec 08, 2022. Its latest funding round was a Seed round on Mar 11, 2024 for $*****. 1 investor participated in its latest round. EIGEN THERAPEUTICS has 8 institutional investors and 4 angel investors.
Here is the list of recent funding rounds of EIGEN THERAPEUTICS:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 11, 2024 | 8163008 | Seed | 8872658 | 1601044 | 2871699 | 6231476 |
Dec 08, 2022 | 9272704 | Seed | 5093935 | 6451592 |
Access funding benchmarks and valuations. Sign up today!View details of EIGEN THERAPEUTICS's funding rounds and investors
EIGEN THERAPEUTICS's founders and board of directors
Founder? Claim ProfileEIGEN THERAPEUTICS's employee count trend
EIGEN THERAPEUTICS has 4 employees as of Sep 26. Here is EIGEN THERAPEUTICS's employee count trend over the years:
Uncover EIGEN THERAPEUTICS's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
EIGEN THERAPEUTICS's Competitors and alternates
Top competitors of EIGEN THERAPEUTICS include BeiGene, Jazz Pharmaceuticals and Kite Pharma. Here is the list of Top 10 competitors of EIGEN THERAPEUTICS, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 81/100 | |
2nd |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 81/100 | |
3rd | Kite Pharma 2009, Los Angeles (United States), Acquired | Developer of cancer immunotherapy products using genetic engineering | $97.7M | 76/100 | |
4th |  Attovia 2023, Fremont (United States), Public | Developer of antibody-based therapeutics for immune-mediated diseases and oncology | $255M | 72/100 | |
5th |  Tango Therapeutics 2017, Cambridge (United States), Public | Developer of drugs for the treatment of cancer | $165M | 72/100 | |
6th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
7th |  Elicio 2012, Cambridge (United States), Public | Developer of vaccines for treating cancer | $47.4M | 72/100 | |
8th |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 72/100 | |
9th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
10th | Developer of immunotherapeutics for the treatment of cancer and other diseases | $861M | 71/100 | ||
1246th |  EIGEN THERAPEUTICS 2021, Redwood City (United States), Seed | Developer of combination therapeutics for cancer treatment | $7M | 37/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on EIGEN THERAPEUTICS's competitors? Click here to see the top ones
EIGEN THERAPEUTICS's Investments and acquisitions
EIGEN THERAPEUTICS has made no investments or acquisitions yet.
Reports related to EIGEN THERAPEUTICS
Here is the latest report on EIGEN THERAPEUTICS's sector:
News related to EIGEN THERAPEUTICS
•
ZAKA VC invests in Eigen Therapeutics, an American biotech companyAIN.Capital•Mar 11, 2024•ZAKA, EIGEN THERAPEUTICS
•
Eigen Therapeutics Emerges From Stealth With $7 Million in Funding to Develop Therapies That Address Cancer HeterogeneityAiThority•Dec 12, 2022•EIGEN THERAPEUTICS, First Round Capital, Builders VC, Alumni Ventures and 2 others
•
Eigen Therapeutics Raises $7M in Seed FundingFinSMEs•Dec 09, 2022•EIGEN THERAPEUTICS, Builders VC, Alumni Ventures, Bioverge and 3 others
•
Priming therapy biotech emerges from stealth with seed funding — and on a hunt for partnersEndPoints News•Dec 08, 2022•EIGEN THERAPEUTICS, First Round Capital, Builders VC, Bioverge and 3 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about EIGEN THERAPEUTICS
Explore our recently published companies
- EmployaLingua - Manchester based, Unfunded company
- Emerald ATM - Sherman Oaks based, 2013 founded, Unfunded company
- Rivra ERP - Unfunded company
- Elland Computers & Mobiles - United Kingdom based, 2016 founded, Unfunded company
- El Rumbo de New York - New York based, 1970 founded, Unfunded company
- El Mirador de Ceuta - Unfunded company
